Increasing its focus in China, Aker BioMarine enters into six new agreements and strategic partnerships that will help strengthen the company's position in pet food and supplements in Asia.
During the prestigious CIIE (China International Import Expo) that took place in Shanghai this past weekend, Aker BioMarine signed an important agreement with China's leading producer of pet food, Gambol Pet Food Group.
On top of that, Aker BioMarine is starting a partnership with three other Chinese pet food companies. Aker BioMarine's krill meal is now on its way to becoming an important ingredient in premium pet food in China.
“China is the world's largest market for marine ingredients and it is an important market for us. The agreement with Gambol is essential to our business as they are one of the most important players in this market. This partnership leverages the credibility and market opportunities in China, and Asia in general, for both of us. If the business development progresses as expected, these agreements alone will make up an important part of our total sales for QRILL Pet next year,” says Matts Johansen, CEO of Aker BioMarine.
Growing our pet focus in China
A Norwegian biotech innovator, Aker BioMarine developing products from krill harvested from Antarctica. All the products contain large amounts of omega-3 that keep both humans and animals all across the globe healthy.
"Now with our strategic partnership in place we are looking forward to establish our products in the Chines pet food industry and become a well-known branded ingredient. We want QRILL Pet to be important for pet food brands and consumers while being associated with optimal pet health. Our strategic partnership provides us the opportunity to influence the Chinese pet food industry in a positive way. Together with our partners we are looking forward to become a significant player in the Chinese pet food market and we are committed to develop a long term strategy together," says Knut Heggen, SVP Qrill Pet Sales
The company has been present on the Chinese market since 2011 and has always been committed to having a local presence in China.
“Today, we have less than 10 employees located in China, but during the next year, we plan to build up the organization by hiring more key employees. Our team has worked extensively with regulatory approvals and product approvals as well as network building, ensuring that we continue to leverage all of the potential possible in this market. Aker BioMarine has a broad customer portfolio in the aquaculture market and these new agreements mark the start of the future here in China for products for humans and pets. We look forward to the opportunity to invest further in the market,” adds Johansen.
About Aker BioMarine
Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, dedicated to improving human and planetary health. Listed on Oslo Stock Exchange, the company develops krill-based ingredients for pharmaceutical, nutraceutical (Superba®, NKO® and K·REAL®), aquaculture (QRILL™ Aqua), and animal feed applications (QRILL™ Pet), including INVI™, a highly concentrated protein isolate, and LYSOVETA™, a targeted transporter of EPA and DHA from krill.
Aker BioMarine’s fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and to customers around the world. The company’s strong focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.